A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function

Clinical trial NCT01761773 · COMPLETED

Trial details

NCT number: NCT01761773
Sponsor: Exelixis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Renal Impairment

Start date: 2012-12-01
Primary completion: 2013-04-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.